review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0966-842X(02)02394-6 |
P698 | PubMed publication ID | 12110210 |
P2093 | author name string | Zsolt Ruzsics | |
Markus Wagner | |||
Ulrich H Koszinowski | |||
P2860 | cites work | Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector | Q24563904 |
Stable propagation of cosmid sized human DNA inserts in an F factor based vector | Q24608728 | ||
Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome | Q24645354 | ||
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products | Q27860842 | ||
An efficient recombination system for chromosome engineering in Escherichia coli | Q29615038 | ||
Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant | Q29615039 | ||
A new logic for DNA engineering using recombination in Escherichia coli | Q29615202 | ||
Fast screening procedures for random transposon libraries of cloned herpesvirus genomes: mutational analysis of human cytomegalovirus envelope glycoprotein genes | Q30656734 | ||
Virus reconstituted from infectious bacterial artificial chromosome (BAC)-cloned murine gammaherpesvirus 68 acquires wild-type properties in vivo only after excision of BAC vector sequences | Q30668724 | ||
Molecular cloning of the guinea pig cytomegalovirus (GPCMV) genome as an infectious bacterial artificial chromosome (BAC) in Escherichia coli | Q31850123 | ||
A ribonucleotide reductase homolog of cytomegalovirus and endothelial cell tropism. | Q31869750 | ||
Cloning and stable maintenance of DNA fragments over 300 kb in Escherichia coli with conventional plasmid-based vectors | Q31997586 | ||
Identification of a boundary domain adjacent to the potent human cytomegalovirus enhancer that represses transcription of the divergent UL127 promoter | Q33800239 | ||
Systematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution. | Q33818345 | ||
Reconstitution of Marek's disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome and characterization of a glycoprotein B-negative MDV-1 mutant | Q33826716 | ||
The major immediate-early gene ie3 of mouse cytomegalovirus is essential for viral growth | Q33826853 | ||
Spontaneous activation of the lytic cycle in cells infected with a recombinant Kaposi's sarcoma-associated virus | Q33866016 | ||
Temperature-Sensitive Mutants of Herpesviruses | Q34033955 | ||
Molecular engineering of the herpes simplex virus genome: Insertion of a second L-S junction into the genome causes additional genome inversions | Q34251950 | ||
A generalized technique for deletion of specific genes in large genomes: alpha gene 22 of herpes simplex virus 1 is not essential for growth. | Q34252704 | ||
Characterization of Marek's disease virus serotype 1 (MDV-1) deletion mutants that lack UL46 to UL49 genes: MDV-1 UL49, encoding VP22, is indispensable for virus growth | Q34330718 | ||
ET-cloning: think recombination first. | Q34334658 | ||
Insertion and deletion mutagenesis of the human cytomegalovirus genome | Q34354191 | ||
Construction of large DNA segments in Escherichia coli | Q34502907 | ||
Construction of a self-excisable bacterial artificial chromosome containing the human cytomegalovirus genome and mutagenesis of the diploid TRL/IRL13 gene | Q34971048 | ||
Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells | Q36173276 | ||
The multiple immune-evasion genes of murine cytomegalovirus are not redundant: m4 and m152 inhibit antigen presentation in a complementary and cooperative fashion | Q36369490 | ||
Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro | Q36465730 | ||
Epstein-Barr virus recombinants from overlapping cosmid fragments | Q36655212 | ||
Yeast artificial chromosome cloning. | Q36716257 | ||
A new bacteriophage P1-derived vector for the propagation of large human DNA fragments | Q36745476 | ||
A cosmid-based system for constructing mutants of herpes simplex virus type 1. | Q36753033 | ||
Activation of immediate-early, early, and late promoters by temperature-sensitive and wild-type forms of herpes simplex virus type 1 protein ICP4 | Q36892074 | ||
Generation of mutant murine cytomegalovirus strains from overlapping cosmid and plasmid clones | Q39539772 | ||
An enhanced packaging system for helper-dependent herpes simplex virus vectors | Q39580097 | ||
Comparison between human cytomegalovirus pUL97 and murine cytomegalovirus (MCMV) pM97 expressed by MCMV and vaccinia virus: pM97 does not confer ganciclovir sensitivity | Q39585516 | ||
Cloning and mutagenesis of the murine gammaherpesvirus 68 genome as an infectious bacterial artificial chromosome | Q39592358 | ||
Genetic evidence of an essential role for cytomegalovirus small capsid protein in viral growth | Q39601968 | ||
Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes | Q39602194 | ||
Glycoproteins E and I of Marek's disease virus serotype 1 are essential for virus growth in cultured cells | Q39605251 | ||
Proteolytic processing of human cytomegalovirus glycoprotein B is dispensable for viral growth in culture | Q39682047 | ||
Viable human cytomegalovirus recombinant virus with an internal deletion of the IE2 86 gene affects late stages of viral replication | Q39682884 | ||
Defined large-scale alterations of the human cytomegalovirus genome constructed by cotransfection of overlapping cosmids | Q39873911 | ||
Genetics of Herpes Simplex Virus | Q40143066 | ||
Techniques in mammalian genome mapping | Q40614532 | ||
Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors | Q40984259 | ||
A facile system for construction of HSV-1 variants: site directed mutation of the UL26 protease gene in HSV-1. | Q41206457 | ||
The products of the UL10 (gM) and the UL49.5 genes of Marek's disease virus serotype 1 are essential for virus growth in cultured cells | Q42674588 | ||
The glycoprotein gp48 of murine cytomegalovirusL proteasome-dependent cytosolic dislocation and degradation | Q42823793 | ||
Cloning of the genomes of equine herpesvirus type 1 (EHV-1) strains KyA and racL11 as bacterial artificial chromosomes (BAC). | Q43537093 | ||
Equine herpesvirus type 1 devoid of gM and gp2 is severely impaired in virus egress but not direct cell-to-cell spread | Q45030750 | ||
Secreted virus-encoded proteins reflect murine cytomegalovirus productivity in organs. | Q45735023 | ||
Allele replacement: an application that permits rapid manipulation of herpes simplex virus type 1 genomes | Q45746975 | ||
Construction in vitro and rescue of a thymidine kinase-deficient deletion mutation of herpes simplex virus. | Q45803647 | ||
Homologous recombination based modification in Escherichia coli and germline transmission in transgenic mice of a bacterial artificial chromosome | Q48611307 | ||
Allelic exchange in Escherichia coli using the Bacillus subtilis sacB gene and a temperature-sensitive pSC101 replicon | Q54696474 | ||
Rapid identification of essential and nonessential herpesvirus genes by direct transposon mutagenesis | Q57083076 | ||
[Genetic analysis of sacB, the structural gene of a secreted enzyme, levansucrase of Bacillus subtilis Marburg] | Q70445937 | ||
P433 | issue | 7 | |
P304 | page(s) | 318-324 | |
P577 | publication date | 2002-07-01 | |
P1433 | published in | Trends in Microbiology | Q15265732 |
P1476 | title | Herpesvirus genetics has come of age. | |
P478 | volume | 10 |
Q35148119 | A modified screening system for loss-of-function and dominant negative alleles of essential MCMV genes |
Q33490133 | A novel Cre recombinase imaging system for tracking lymphotropic virus infection in vivo |
Q34000122 | A replicating cytomegalovirus-based vaccine encoding a single Ebola virus nucleoprotein CTL epitope confers protection against Ebola virus |
Q40072508 | A self-excisable infectious bacterial artificial chromosome clone of varicella-zoster virus allows analysis of the essential tegument protein encoded by ORF9. |
Q38889900 | An endocytic YXXΦ (YRRF) cargo sorting motif in the cytoplasmic tail of murine cytomegalovirus AP2 'adapter adapter' protein m04/gp34 antagonizes virus evasion of natural killer cells |
Q30320280 | Analysis of human cytomegalovirus oriLyt sequence requirements in the context of the viral genome |
Q33510430 | Cloning of Bovine herpesvirus type 1 and type 5 as infectious bacterial artifical chromosomes |
Q40125719 | Cloning of full length genome of varicella-zoster virus vaccine strain into a bacterial artificial chromosome and reconstitution of infectious virus |
Q39630573 | Cloning of the Epstein-Barr Virus-Related Rhesus Lymphocryptovirus as a Bacterial Artificial Chromosome: a Loss-of-Function Mutation of the rhBARF1 Immune Evasion Gene |
Q34975353 | Cloning of the Full-Length Rhesus Cytomegalovirus Genome as an Infectious and Self-Excisable Bacterial Artificial Chromosome for Analysis of Viral Pathogenesis |
Q40659928 | Cloning of the genomes of human cytomegalovirus strains Toledo, TownevarRIT3, and Towne long as BACs and site-directed mutagenesis using a PCR-based technique |
Q36594136 | Cloning of the koi herpesvirus genome as an infectious bacterial artificial chromosome demonstrates that disruption of the thymidine kinase locus induces partial attenuation in Cyprinus carpio koi. |
Q45400946 | Comparative sequence analysis of a highly oncogenic but horizontal spread-defective clone of Marek's disease virus |
Q31094095 | Comprehensive mutational analysis of a herpesvirus gene in the viral genome context reveals a region essential for virus replication |
Q40629451 | Constitutive signaling of the human cytomegalovirus-encoded receptor UL33 differs from that of its rat cytomegalovirus homolog R33 by promiscuous activation of G proteins of the Gq, Gi, and Gs classes. |
Q43247382 | Construction and growth properties of bovine herpesvirus type 5 recombinants defective in the glycoprotein E or thymidine kinase gene or both. |
Q31063997 | Cytomegalovirus replicon-based regulation of gene expression in vitro and in vivo |
Q40588191 | DNA immunization with a herpes simplex virus 2 bacterial artificial chromosome |
Q35753517 | Development of herpesvirus-based episomally maintained gene delivery vectors |
Q39698437 | Effective inhibition of K(b)- and D(b)-restricted antigen presentation in primary macrophages by murine cytomegalovirus |
Q39765355 | Epstein-Barr virus facilitates the malignant potential of immortalized epithelial cells: from latent genome to viral production and maintenance |
Q37835507 | Equine herpesvirus 4: recent advances using BAC technology. |
Q36953959 | Expansion of protective CD8+ T-cell responses driven by recombinant cytomegaloviruses |
Q26866437 | Fluorescent Protein Approaches in Alpha Herpesvirus Research |
Q40721423 | Functional domains of murine cytomegalovirus nuclear egress protein M53/p38. |
Q90135524 | HLA-B locus products resist degradation by the human cytomegalovirus immunoevasin US11 |
Q34247863 | Herpesvirus BACs: past, present, and future |
Q37528518 | Highly Efficient CRISPR/Cas9-Mediated Homologous Recombination Promotes the Rapid Generation of Bacterial Artificial Chromosomes of Pseudorabies Virus |
Q28293959 | Human herpesvirus 6 encoded glycoprotein Q1 gene is essential for virus growth |
Q30320331 | Identification of a mouse cytomegalovirus gene selectively targeting CD86 expression on antigen-presenting cells. |
Q30831669 | Incorporation of a lambda phage recombination system and EGFP detection to simplify mutagenesis of Herpes simplex virus bacterial artificial chromosomes |
Q40180359 | Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV). |
Q36371228 | Major histocompatibility complex class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus |
Q36402602 | NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145. |
Q38354047 | Pharmacological and biochemical characterization of human cytomegalovirus-encoded G protein-coupled receptors |
Q33560444 | Preliminary study of the UL55 gene based on infectious Chinese virulent duck enteritis virus bacterial artificial chromosome clone |
Q40545950 | Production of high-titer Epstein-Barr virus recombinants derived from Akata cells by using a bacterial artificial chromosome system |
Q33279597 | Random screening for dominant-negative mutants of the cytomegalovirus nuclear egress protein M50 |
Q59354854 | Rapid and efficient in vitro excision of BAC sequences from herpesvirus genomes using Cre-mediated recombination |
Q39713933 | Rapid and efficient introduction of a foreign gene into bacterial artificial chromosome-cloned varicella vaccine by Tn7-mediated site-specific transposition. |
Q40130517 | Rapid engineering of bacterial reporter gene fusions by using Red recombination. |
Q75320465 | Re-evaluation and in silico annotation of the Tupaia herpesvirus proteins |
Q34360228 | Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties. |
Q33517637 | Red-mediated transposition and final release of the mini-F vector of a cloned infectious herpesvirus genome |
Q39796541 | Replication-competent bacterial artificial chromosomes of Marek's disease virus: novel tools for generation of molecularly defined herpesvirus vaccines. |
Q37452466 | Role of ORF74-encoded viral G protein-coupled receptor in human herpesvirus 8 lytic replication |
Q39748997 | Role of murine cytomegalovirus US22 gene family members in replication in macrophages |
Q35123249 | SUMOylation of the human cytomegalovirus 72-kilodalton IE1 protein facilitates expression of the 86-kilodalton IE2 protein and promotes viral replication |
Q40677826 | Small internal deletions in the human cytomegalovirus IE2 gene result in nonviable recombinant viruses with differential defects in viral gene expression. |
Q36315171 | Targeted deletion of regions rich in immune-evasive genes from the cytomegalovirus genome as a novel vaccine strategy. |
Q41170179 | The Canonical Immediate Early 3 Gene Product pIE611 of Mouse Cytomegalovirus Is Dispensable for Viral Replication but Mediates Transcriptional and Posttranscriptional Regulation of Viral Gene Products |
Q33987514 | The extracellular domain of herpes simplex virus gE is indispensable for efficient cell-to-cell spread: evidence for gE/gI receptors |
Q37173390 | The genetic basis of human cytomegalovirus resistance and current trends in antiviral resistance analysis |
Q34345137 | The human cytomegalovirus ribonucleotide reductase homolog UL45 is dispensable for growth in endothelial cells, as determined by a BAC-cloned clinical isolate of human cytomegalovirus with preserved wild-type characteristics |
Q36678423 | Update on the current status of cytomegalovirus vaccines |
Q38274756 | Use of a current varicella vaccine as a live polyvalent vaccine vector |
Q33833779 | Use of a murine cytomegalovirus K181-derived bacterial artificial chromosome as a vaccine vector for immunocontraception. |
Q91677092 | Utilization of herpesviridae as recombinant viral vectors in vaccine development against animal pathogens |
Q35382985 | Virus progeny of murine cytomegalovirus bacterial artificial chromosome pSM3fr show reduced growth in salivary Glands due to a fixed mutation of MCK-2 |